Palifermin in theManagement of Mucositis in Hematological Malignancies: Current Evidences and Future Perspectives
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
7
Page:
305-312
Author(s):
P. Niscola, L. Scaramucci, M. Giovannini, M. Ales, F. Bondanini, L. Cupelli, T. Dentamaro, M. Lamanda, G. Natale, R. Palumbo, C. Romani, A. Tendas, B. Tolu, L. Violo and P. de Fabritiis
Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Journal:
Current Gene Therapy
Volume:
9
Page:
396-408
Author(s):
Juan F. Vera, Malcolm K. Brenner and Gianpietro Dotti
Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities
Journal:
Current Drug Metabolism
Volume:
10
Page:
861-874
Author(s):
Gigi N.C. Chiu, Man-Yi Wong, Leong-Uung Ling, Ishaque M. Shaikh, Kuan-Boone Tan, Anumita Chaudhury and Bee-Jen Tan
WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
787-797
Author(s):
Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Zheyu Li, Hiroko Nakajima, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Yusuke Oji, Ichiro Kawase and Haruo Sugiyama
Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2652-2664
Author(s):
Robert J. Kreitman
Ribonucleases and ImmunoRNases as Anticancer Drugs
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2665-2675
Author(s):
S. M. Rybak, M. A.E. Arndt, T. Schirrmann, S. Dubel and J. Krauss
P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
617-625
Author(s):
C. Tripodo, A. M. Florena, P. Macor, A. Di Bernardo, R. Porcasi, C. Guarnotta, S. Ingrao, M. Zerilli, E. Secco, M. Todaro, F. Tedesco and V. Franco
Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising
Journal:
Current Drug Metabolism
Volume:
10
Page:
547-566
Author(s):
Guillermo Gervasini
Impact of PET on the Radiation Treatment of Hodgkins Lymphoma
Journal:
Current Radiopharmaceuticals
Volume:
2
Page:
169-174
Author(s):
Annibale Versari, Cinzia Iotti and Francesco Merli
Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
2212-2234
Author(s):
Tadeusz Robak